GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
54.47
+0.25 (0.46%)
At close: Apr 28, 2026, 4:00 PM EDT
54.71
+0.24 (0.44%)
After-hours: Apr 28, 2026, 5:34 PM EDT
GSK Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for GSK.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GSK stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Jan 6, 2026 |
| Jefferies | Jefferies | Hold → Strong Buy Initiates n/a | Hold → Strong Buy | Initiates | n/a | n/a | Oct 27, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 31, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 8, 2024 |
Financial Forecast
Revenue This Year
34.95B
from 32.67B
Increased by 6.99%
Revenue Next Year
36.42B
from 34.95B
Increased by 4.19%
EPS This Year
1.86
from 1.39
Increased by 34.00%
EPS Next Year
2.02
from 1.86
Increased by 8.71%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 36.4B | 38.3B | ||||||
| Avg | 35.0B | 36.4B | ||||||
| Low | 32.4B | 33.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 11.4% | 9.7% | ||||||
| Avg | 7.0% | 4.2% | ||||||
| Low | -0.8% | -3.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 2.03 | 2.37 | ||||||
| Avg | 1.86 | 2.02 | ||||||
| Low | 1.69 | 1.76 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 46.0% | 27.6% | ||||||
| Avg | 34.0% | 8.7% | ||||||
| Low | 21.5% | -5.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.